浙江尖(jian)峰(feng)藥業有(you)限(xian)公(gong)司成(cheng)立于1998年12月31日,系上市公(gong)司浙江尖(jian)峰(feng)集(ji)團股份有(you)限(xian)公(gong)司(股票代碼:600668)下屬(shu)的全資子公(gong)司。
公(gong)司下屬全資、控股(gu)和參股(gu)藥(yao)品生產(chan)企(qi)業(ye)6家(jia)、藥(yao)品經(jing)營企(qi)業(ye)3家(jia)、國家(jia)博(bo)士(shi)后科研工(gong)作站(zhan)(zhan)4家(jia)、省級院(yuan)士(shi)專(zhuan)家(jia)工(gong)作站(zhan)(zhan)2家(jia),擁有國際、國內(nei)藥(yao)品發明專(zhuan)利52項(xiang)。公(gong)司先后被(bei)多次評為高新技術(shu)企(qi)業(ye)、國家(jia)知識產(chan)權示范企(qi)業(ye),浙江(jiang)省創新型示范企(qi)業(ye)、浙江(jiang)省專(zhuan)利示范企(qi)業(ye)。
公(gong)司本著“立(li)尖(jian)峰志(zhi),做(zuo)精品藥(yao)(yao)(yao)(yao)”的(de)企業精神,追求“科技(ji)造就健康”的(de)經營(ying)(ying)理念(nian),堅持(chi)以開發(fa)高(gao)技(ji)術含量、高(gao)附加值的(de)化(hua)學原料(liao)藥(yao)(yao)(yao)(yao)以及(ji)新(xin)型(xing)的(de)化(hua)學藥(yao)(yao)(yao)(yao)、中(zhong)(zhong)成藥(yao)(yao)(yao)(yao)制劑為(wei)新(xin)藥(yao)(yao)(yao)(yao)研(yan)(yan)發(fa)方向,以項(xiang)目和(he)資金為(wei)紐(niu)帶(dai),實現了(le)高(gao)質量發(fa)展(zhan)。與德國(guo)(guo)研(yan)(yan)究機構合(he)(he)作(zuo),成立(li)中(zhong)(zhong)德合(he)(he)資浙江爾嬰藥(yao)(yao)(yao)(yao)品有(you)限(xian)公(gong)司,專業從(cong)事(shi)嬰幼兒用藥(yao)(yao)(yao)(yao)的(de)研(yan)(yan)發(fa)生產(chan)(chan)(chan)與經營(ying)(ying);參股(gu)北京慧寶源生物技(ji)術股(gu)份有(you)限(xian)公(gong)司,合(he)(he)作(zuo)開發(fa)國(guo)(guo)家(jia)一類抗腫瘤新(xin)藥(yao)(yao)(yao)(yao),拓(tuo)展(zhan)中(zhong)(zhong)成藥(yao)(yao)(yao)(yao)市場;控股(gu)上海北卡醫(yi)(yi)藥(yao)(yao)(yao)(yao)技(ji)術有(you)限(xian)公(gong)司,專業從(cong)事(shi)醫(yi)(yi)藥(yao)(yao)(yao)(yao)化(hua)工中(zhong)(zhong)間體、醫(yi)(yi)藥(yao)(yao)(yao)(yao)原料(liao)藥(yao)(yao)(yao)(yao)的(de)研(yan)(yan)發(fa)、生產(chan)(chan)(chan)和(he)經營(ying)(ying),拓(tuo)展(zhan)高(gao)端醫(yi)(yi)藥(yao)(yao)(yao)(yao)原料(liao)藥(yao)(yao)(yao)(yao)和(he)中(zhong)(zhong)間體的(de)國(guo)(guo)際市場。公(gong)司將(jiang)堅持(chi)科技(ji)創新(xin),以技(ji)術和(he)產(chan)(chan)(chan)品為(wei)載體,推進(jin)產(chan)(chan)(chan)學研(yan)(yan)的(de)融合(he)(he),不斷提升公(gong)司管(guan)理水平和(he)品牌影響力,走國(guo)(guo)際化(hua)發(fa)展(zhan)道路。